LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 7.77 | 84.90 | 853 | 411 | 2.0742 | 1.7557 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 9.47 | 84.90 | 2 | 447 | 0.0045 | -0.7905 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 9.47 | 84.90 | 953 | 447 | 2.1299 | 1.7414 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 9.47 | 84.90 | 4 | 447 | 0.0089 | -0.7203 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 9.47 | 84.90 | 948 | 447 | 2.1188 | 1.7354 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 11.18 | 84.90 | 10 | 492 | 0.0203 | -0.5698 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 11.18 | 84.90 | 1004 | 492 | 2.0392 | 1.6489 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 11.18 | 84.90 | 10 | 492 | 0.0203 | -0.5698 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 11.18 | 84.90 | 1013 | 492 | 2.0574 | 1.6582 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.88 | 84.90 | 95 | 531 | 0.1789 | 0.0434 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.88 | 84.90 | 1084 | 531 | 2.0414 | 1.6195 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.88 | 84.90 | 16 | 531 | 0.0301 | -0.4679 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.88 | 84.90 | 1033 | 531 | 1.9454 | 1.5722 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 14.58 | 84.90 | 372 | 663 | 0.5607 | 0.6456 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 14.58 | 84.90 | 1107 | 663 | 1.6687 | 1.3768 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 14.58 | 84.90 | 573 | 663 | 0.8637 | 0.9036 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 14.58 | 84.90 | 1101 | 663 | 1.6596 | 1.3725 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 16.29 | 84.90 | 565 | 766 | 0.7368 | 0.8166 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 16.29 | 84.90 | 1172 | 766 | 1.5283 | 1.2858 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 16.29 | 84.90 | 779 | 766 | 1.0158 | 1.0099 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 16.29 | 84.90 | 1146 | 766 | 1.4944 | 1.2698 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 17.99 | 84.90 | 643 | 898 | 0.7153 | 0.8125 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 17.99 | 84.90 | 1210 | 898 | 1.3460 | 1.1824 | MN20160318_Q02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 17.99 | 84.90 | 873 | 898 | 0.9711 | 0.9829 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 17.99 | 84.90 | 1172 | 898 | 1.3037 | 1.1620 | MN20160318_Q02 | L09 |